| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 96,978 | 388 | 436 | 42,620 | | Cost of Revenue | (945) | 945 |
-
| (40,635) | | | Gross Profit | 97,923 | (557) | 436 | 83,255 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,176 | 1,785 | 2,268 | 4,084 | | Non Recurring |
-
|
-
|
-
| 1,064 | | Others | 8,706 | 13 | (73) | 41,249 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 68,041 | (2,355) | (1,759) | 36,858 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | (7) |
-
|
-
| | Earnings Before Interest And Taxes | 68,048 | (2,362) | (1,729) | 36,887 | | Interest Expense | 44,660 | 1,083 | 1,039 | 2,861 | | Income Before Tax | 23,388 | (3,445) | (2,768) | 34,026 | | Income Tax Expense | (77,070) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 100,428 | (3,415) | (2,768) | 34,026 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 100,428 | (3,415) | (2,768) | 34,026 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $100,428 | ($3,415) | ($2,768) | $34,026 |
|
0.26% Nasdaq 0.00%
Income Statement
